Stephen A. Trowbridge - 28 Oct 2026 Form 4 Insider Report for ANGIODYNAMICS INC (ANGO)

Reporting relationship: EVP and CFO
Issuer ticker: ANGO
Reported as of: 28 Oct 2026
Net transaction value: -$310,688
SEC form: 4
Accepted by SEC: 30 Oct 2026, 16:15:09 UTC
Prior SEC filing: 24 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Lawrence T. Weiss, as Attorney in Fact

Filing notes and source

Key filing fact

Stephen A. Trowbridge filed Form 4 for ANGIODYNAMICS INC (ANGO) on 30 Oct 2026.

Key facts

This page summarizes Stephen A. Trowbridge's Form 4 filing for ANGIODYNAMICS INC (ANGO).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 30 Oct 2026, 16:15.

Change

Previous filing in this sequence was filed on 24 Jul 2026.
Current net transaction value: -$310,688.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001624250 Primary reporting owner

Trowbridge Stephen A

Relationship: EVP and CFO
Address: 14 PLAZA DRIVE, LATHAM
Signature: /s/ Lawrence T. Weiss, as Attorney in Fact
Signature date: 30 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANGO transaction

Common Stock

Sale

Transaction value: -$20,932
Shares: -1,720
Change %: -0.56%
Price: $12.17
Shares after: 304,076
Date: 28 Oct 2026
Ownership: Direct
Footnotes: F1

ANGO transaction

Common Stock

Sale

Transaction value: -$289,756
Shares: -23,615
Change %: -7.8%
Price: $12.27
Shares after: 280,461
Date: 29 Oct 2026
Ownership: Direct
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.15 to $12.20, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.07 to $12.35 inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 2.